For the remaining genes, OR10A3, RPF1, KΑTNA1, and CES4A, in our risk score model, no specific relationship to cancer had been reported yet, further exploration should be carried out for their roles in the prognosis in DLBCL patients. This evidence concerns the gene RPF1 and diffuse large B-cell lymphoma.